News
The number of people suffering from osteoarthritis is expected to top 1 billion by 2050. The biggest risk factor for the ...
At the University of British Columbia, the Blakney Lab is focused on developing vaccines and therapies using self-amplifying ...
Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsLavina Talukdar - Senior Vice President, ...
Meta Platforms (NASDAQ: META) stock climbed 6.2% after the Facebook and Instagram parent reported better-than-expected ...
We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a ...
With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...
The cost of a new randomized trial to evaluate the vaccine’s ability to prevent disease could run into tens of millions of ...
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...
South African global pharmaceutical giant Aspen Pharmacare has found itself caught in Trump tariff-related market volatility, ...
11d
Investing News Network on MSNTop 5 Canadian Biotech Stocks in 2025Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector ...
13d
Barchart on MSNWhat to Expect From Moderna's Q1 2025 Earnings ReportValued at a market cap of $9.6 billion, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results